60 Degrees Pharmaceuticals, Inc. (SXTP) is a Washington, D.C.-based specialty pharmaceutical company dedicated to advancing innovative therapies for the prevention and treatment of infectious diseases. By focusing on addressing critical unmet medical needs, the company harnesses state-of-the-art research and development to deliver effective treatment options that improve health outcomes across various patient demographics. Positioned as a key contributor to enhancing public health, 60 Degrees Pharmaceuticals represents a noteworthy investment opportunity for institutional investors targeting the dynamic healthcare sector. Show more

Location: 1025 CONNECTICUT AVENUE NW, WASHINGTON, DC, UNITED STATES, 20036, Washington, DC, 20036, USA | Website: https://www.60degreespharma.com | Industry: BIOTECHNOLOGY | Sector: HEALTHCARE

Market Cap

5.342M

52 Wk Range

$1.36 - $15.40

Previous Close

$4.15

Open

$3.71

Volume

3,609,469

Day Range

$3.46 - $4.06

Enterprise Value

11.84M

Cash

4.116M

Avg Qtr Burn

-2.109M

Insider Ownership

2.05%

Institutional Own.

5.56%

Qtr Updated

09/30/25

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
Arakoda Details Malaria	Approved Quarterly sales	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Arakoda/Tafenoquine (Antimalarial Agent) Details Acute Canine Babesiosis	NDA Submission	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
SJ733 Details Malaria	Phase 2b Initiation	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Arakoda (Tafenoquine) Details Babesiosis	Phase 2a Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Tafenoquine Details COVID-19	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.